Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to BioFluidica in September, 2019 for $837,994.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA224848-02 | Phase II | 837,994 | September 18, 2019 | |||||||
A SBIR Phase I contract was awarded to BioFluidica in July, 2018 for $348,768.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA224848-01A1 | Phase I | 348,768 | July 18, 2018 | |||||||
A SBIR Phase I contract was awarded to BioFluidica in May, 2019 for $291,545.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HD098942-01 | Phase I | 291,545 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to BioFluidica in July, 2018 for $239,138.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA232848-01 | Phase I | 239,138 | July 13, 2018 | |||||||
A SBIR Phase I contract was awarded to BioFluidica in September, 2018 for $286,548.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA228923-01A1 | Phase I | 286,548 | September 18, 2018 | |||||||
A SBIR Phase I contract was awarded to BioFluidica in September, 2015 for $399,681.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EB021212-01 | Phase I | 399,681 | September 17, 2015 | |||||||
A SBIR Phase II contract was awarded to BioFluidica in September, 2015 for $1,496,183.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA203221-01 | Phase II | 1,496,183 | September 24, 2015 | |||||||
A SBIR Phase II contract was awarded to BioFluidica in March, 2017 for $1,510,296.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA213595-01 | Phase II | 1,510,296 | March 1, 2017 | |||||||
A SBIR Phase II contract was awarded to BioFluidica for $999,873.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CA130071 | Phase II | 999,873 | ||||||||
A SBIR Phase I contract was awarded to BioFluidica for $199,517.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO201000066 | Phase I | 199,517 |